Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, announced that its CytoSure Interpret Software can now seamlessly transfer array comparative genomic hybridisation (aCGH) aberration data directly to Cartagenia's Bench constitutional cytogenetics platform. This helps cytogeneticists accurately correlate genotypic findings with known clinical phenotypes. Further details of this new functionality will be presented in two workshops at the European Human Genetics Conference 2010 in Gothenburg, Sweden, 12-15 June.

With the ability to automatically detect CNV aberrations, CytoSure Interpret Software generates reliable and reproducible results, which can be cross referenced with external aberration databases for accurate data interpretation. These results can now be effortlessly transferred to Cartagenia's Bench platform, allowing additional data management options - including quick and secure data sharing within, and across, various research facilities - and support for genotypephenotypecorrelation analysis.

Founded by Professor Ed Southern, Oxford Gene Technology (OGT) provides innovative clinical genetics and diagnostic solutions to advance molecular medicine.

Cartagenia provides patient-based diagnostic knowledge, systems, and services which equip genetics laboratories to perform clinically relevant genetic analyses and obtain results quickly, efficiently, and in a way that enables clinicians to deliver high-standing genetic diagnosis and counselling services.